AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PACIFIC EDGE LTD

0.105

+0.000

Volume:- -

Turnover:- -

Market Cap:85.25M

PE:-3.19

High:0.105

Open:0.105

Low:0.105

Close:0.105

Loading ...

Overview Company News Filings

Pacific Edge's Processed Tests at Laboratories Up Nearly 7% in Fiscal Q4; Shares Rise 3%

MT Newswires Live

Pacific Edge's Cxbladder Triage Included as Standard of Care by American Urological Association

MT Newswires Live

ASX Runners of the Week: Wide Open, Pacific, Forbidden Foods & Olympio

The Sydney Morning Herald

Global Penny Stocks To Watch In February 2025

Simply Wall St.

Pacific Edge’s Cxbladder Triage biomarker test recognised as standard of care in AUA guideline update

Why this ASX small cap stock just rocketed 145%

New Zealand Shares Drop Amid Tech Drag; Pacific Edge Climbs 7% on Medicare Extension

MT Newswires Live

Pacific Edge's Cxbladder Medicare Coverage Gets Two-Month Extension; Shares Up 7%

MT Newswires Live

New Zealand Shares Flat, Asian Shares Mixed Amid Tariff Fears; Inflation Steady in Q4 2024

MT Newswires Live

Australian Shares to Open Higher Amid Wall Street Gains; Woodside 2024 Production at Top End of Guidance

MT Newswires Live

Pacific Edge's Laboratory Throughput Up 0.7% in Fiscal Q3; US Injunction Mulled in Wake of Novitas Decision

MT Newswires Live

New Zealand Shares Fall as Upbeat US Jobs Report Weighs on Rate Cut Bets; Pacific Edge Crashes 55% on Medicare Decision

MT Newswires Live

Pacific Edge Plunges to All-Time Low as Confirms US Medicare Exclusion

MT Newswires Live

ASX Market Open: Sharp Oz downturn after Wall Street bucks on ‘surprising’ jobs data | Jan 13, 2025

The Market Herald

Pacific Edge Requests Trading Halt

MT Newswires Live

3 Promising Penny Stocks With Market Caps Of US$50M

Simply Wall St.

Pebblebrook Extends $787 Million in Debt Maturities, Including Term Loan, Credit Facility

MT Newswires Live

Here's Why We're Watching Pacific Edge's (NZSE:PEB) Cash Burn Situation

Simply Wall St.

New Zealand Shares Rally on Central Bank's Supersized Rate Cut

MT Newswires Live

Pacific Edge Tests Processed in Fiscal Q2 Fall 2%; Shares Down 4%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PEB.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PEB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PEB.AU\",,,,,undefined,":{"symbol":"PEB.AU","market":"AU","secType":"STK","nameCN":"PACIFIC EDGE LTD","latestPrice":0.105,"timestamp":1744870320000,"preClose":0.105,"halted":0,"volume":0,"delay":0,"nameEN":"PACIFIC EDGE LTD","floatShares":726160840,"shares":811915974,"eps":-0.032941073217460995,"marketStatus":"Market Closed","change":0,"latestTime":"04-17 16:12:00 AEST","open":0.105,"high":0.105,"low":0.105,"amount":0,"amplitude":0,"askPrice":0.125,"askSize":3577,"bidPrice":0.105,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-0.032941073217460995,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.105,"openAndCloseTimeList":[[1744848000000,1744869600000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PEB.AU\",,,,,undefined,":{"symbol":"PEB.AU","floatShares":726160840,"roa":"-30.52%","roe":"-52.84%","lyrEps":-0.03386,"shares":811915974,"dividePrice":0,"high":0.105,"amplitude":0,"preClose":0.105,"low":0.105,"week52Low":0.05,"pbRate":"2.26","psRate":"4.06","week52High":0.18,"institutionHeld":0,"latestPrice":0.105,"committee":-0.4091,"eps":-0.032941073217460995,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.032941073217460995,"open":0.105,"prevYearClose":0.135,"prevWeekClose":0.115,"prevMonthClose":0.11,"prevQuarterClose":0.11,"fiveDayClose":0.105,"twentyDayClose":0.11,"sixtyDayClose":0.058},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PEB.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524223604","title":"Pacific Edge's Processed Tests at Laboratories Up Nearly 7% in Fiscal Q4; Shares Rise 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524223604","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524223604?lang=en_us&edition=fundamental","pubTime":"2025-04-04 11:00","pubTimestamp":1743735604,"startTime":"0","endTime":"0","summary":"Pacific Edge  reported a 6.8% increase in tests processed at its laboratories in the fourth quarter of fiscal 2025 compared with the prior three-month period, according to a Friday filing with the Australian and New Zealand bourses.Total laboratory throughput rose to 7,577 tests from 7,092 tests between the third and fourth fiscal quarters.However, total volumes for the full fiscal year ended March declined nearly 12% to 28,894 tests from 32,633 in the prior fiscal year. The decline reflected lower sales force due to the uncertainty over Medicare coverage of Cxbladder, per the filing.Pacific Edge's shares were up 3% in New Zealand and by 4% in Australia in recent Friday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","PEB.NZ","XAO.AU","BK7067","XJO.AU","PEB.AU"],"gpt_icon":0},{"id":"2516578262","title":"Pacific Edge's Cxbladder Triage Included as Standard of Care by American Urological Association","url":"https://stock-news.laohu8.com/highlight/detail?id=2516578262","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516578262?lang=en_us&edition=fundamental","pubTime":"2025-03-03 11:01","pubTimestamp":1740970871,"startTime":"0","endTime":"0","summary":"Pacific Edge  said its product Cxbladder Triage has been included by the American Urological Association as the standard of care in an amendment to its clinical guideline for microhematuria patients, according to a Friday filing with the Australian and New Zealand bourses.The guideline mentions the product as the only urine-based biomarker test that has \"Grade A\" evidence from a randomized controlled trial in support of this recommendation, the filing said.Company shares rose 5% in recent Monday trade in New Zealand and jumped almost 22% in Australia.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","BK7067","AFG","BK4124","XJO.AU","XAO.AU","SMP","PEB.AU","BK4107","BK4117"],"gpt_icon":0},{"id":"2514234218","title":"ASX Runners of the Week: Wide Open, Pacific, Forbidden Foods & Olympio","url":"https://stock-news.laohu8.com/highlight/detail?id=2514234218","media":"The Sydney Morning Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514234218?lang=en_us&edition=fundamental","pubTime":"2025-02-28 17:34","pubTimestamp":1740735240,"startTime":"0","endTime":"0","summary":"The ASX has finished off an uneasy week of trading on further shaky footing, as bank stocks continued to release weak December data and United States consumer sentiment began to sour.Shipping logistics giant WiseTech - which exploded into prominence post COVID-19 lockdowns as global trade routes went into turmoil - endured another week of public lambasting, which saw tens of billions of dollars wiped from its market cap. This week’s pandemonium came at the hands of four board directors, who quit on Monday citing “intractable differences” around founder and former-CEO Richard White’s role at the company.This week’s Bulls N’ Bears ASX Runner of the Week is…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.smh.com.au/business/companies/asx-runners-of-the-week-wide-open-pacific-forbidden-foods-and-olympio-20250228-p5lg22.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smh_stock","symbols":["OLY.AU","WOA.AU","XJO.AU","AUA.AU","BK7104","BK7067","PEB.AU","BK7003","BK7141","XAO.AU","BK7050","BK7117","FFF.AU","XKO.AU"],"gpt_icon":0},{"id":"2514343253","title":"Global Penny Stocks To Watch In February 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514343253","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514343253?lang=en_us&edition=fundamental","pubTime":"2025-02-28 17:05","pubTimestamp":1740733534,"startTime":"0","endTime":"0","summary":"Global markets have recently faced a turbulent period, with U.S. stocks experiencing declines amid geopolitical tensions and consumer spending concerns, while European indices displayed cautious optimism. Despite these market challenges, certain investment opportunities continue to attract attention, particularly in the realm of penny stocks. Although the term \"penny stocks\" might seem outdated, these typically smaller or newer companies offer unique growth potential when backed by strong financials and solid fundamentals. In this article, we spotlight several penny stocks that could stand out as hidden gems with promising prospects for investors seeking affordable entry points into the market.Click here to see the full list of 5,745 stocks from our Global Penny Stocks screener.Overview: Pacific Edge Limited is a cancer diagnostics company that focuses on researching, developing, and commercializing tools for early cancer detection and management across New Zealand, the United States, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/global-penny-stocks-watch-february-090534347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7067","PEB.AU"],"gpt_icon":0},{"id":"2514839323","title":"Pacific Edge’s Cxbladder Triage biomarker test recognised as standard of care in AUA guideline update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514839323","media":"Small Caps","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514839323?lang=en_us&edition=fundamental","pubTime":"2025-02-28 10:48","pubTimestamp":1740710893,"startTime":"0","endTime":"0","summary":"New Zealand-based cancer diagnostics company Pacific Edge  has had its Cxbladder Triage test included as a standard of care by the American Urological Association .In a major amendment to the 2020 AUA microhematuria guideline, the AUA panel has incorporated language for the use of urine-based biomarkers for intermediate-risk patients.Most notably, it highlighted Cxbladder Triage as the only urine-based biomarker test with ‘Grade A’ evidence from a randomised controlled trial in support of this recommendation.Pacific Edge chief medical officer Dr Tamer Aboushwareb said the company welcomed the authoritative finding, which reinforces best practice within the urological industry and the adoption of Cxbladder in hematuria evaluation.He said the result paves the way for future Cxbladder products – such as the company’s next-generation Triage Plus test, which is designed for use beyond intermediate-risk hematuria patients – to demonstrate equivalent or better performance than Cxbladder Triag","market":"hk","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/02/Pacific-Edge-ASX-PEB-American-Urological-Association-Cxbladder-Triage.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/02/Pacific-Edge-ASX-PEB-American-Urological-Association-Cxbladder-Triage.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/pacific-edge-cxbladder-triage-biomarker-test-standard-care-aua-guideline-update/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK7003","LCD.AU","BK7067","AUA.AU","PEB.AU"],"gpt_icon":0},{"id":"2514236387","title":"Why this ASX small cap stock just rocketed 145%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514236387","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514236387?lang=en_us&edition=fundamental","pubTime":"2025-02-28 08:16","pubTimestamp":1740701762,"startTime":"0","endTime":"0","summary":"Pacific Edge Ltd  shares are catching the eye of investors on Friday. In morning trade, the ASX small cap stock was up as much as 145% to 13.5 cents. The cancer diagnostics company's shares have pulled back since then but remain up 100% at the time of writing. Why is the ASX small cap stock rocketing?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/28/why-this-asx-small-cap-stock-just-rocketed-145/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4080","BK7067","BK7003","BK4231","MAC.AU","MAC","AUA.AU","LCD.AU","BK4551","PEB.AU","BK7110"],"gpt_icon":0},{"id":"2506550801","title":"New Zealand Shares Drop Amid Tech Drag; Pacific Edge Climbs 7% on Medicare Extension","url":"https://stock-news.laohu8.com/highlight/detail?id=2506550801","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506550801?lang=en_us&edition=fundamental","pubTime":"2025-01-28 12:50","pubTimestamp":1738039839,"startTime":"0","endTime":"0","summary":"New Zealand shares fell Tuesday as a tech-led decline on Wall Street dragged the benchmark index, while Asian shares were mixed amid Lunar New Year festivities.The S&P/NZX 50 Index was down 0.3%, or 4","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4533","LU0476273544.USD","T10G.NZ","LU0154236417.USD","PEB.AU","LU1814569148.SGD","NZ50G.NZ","LU1244550577.SGD","LU1261432733.SGD","2NVD.UK","LU1923622291.USD","NVIW.SI","NVDY","LU2357125470.USD","LU2417539215.USD","NZ20C.NZ","SG9999014575.USD","LU0109391861.USD","LU0234570918.USD","NVDD","LU1852331112.SGD","SKT.AU","LU1548497426.USD","LU1037948897.HKD","3NVD.UK","LU1718418525.SGD","IE0034235303.USD","NVD2.UK","LU1037948541.HKD","LU1242518931.SGD","LU1791710582.SGD","NVD","SNVD.UK","NVDU","IE00BKDWB100.SGD","LU1721428933.USD","NVDS.UK","LU0124676726.USD","NVD3.UK","LU0320765059.SGD","NVDX","IE00BMPRXR70.SGD","LU0788109477.HKD","IE00B19Z8W00.USD","IE00BMPRXQ63.HKD","LU0061474960.USD","NVDS","NVDA","BK4581"],"gpt_icon":1},{"id":"2506552364","title":"Pacific Edge's Cxbladder Medicare Coverage Gets Two-Month Extension; Shares Up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506552364","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506552364?lang=en_us&edition=fundamental","pubTime":"2025-01-28 12:00","pubTimestamp":1738036828,"startTime":"0","endTime":"0","summary":"Pacific Edge  said the Medicare coverage for its flagship Cxbladder test has been extended by two months to Thursday, April 24, according to a Monday filing with the New Zealand and Australian bourses.Last Jan. 22, the cancer diagnostics company disclosed plans to seek a preliminary injunction in the US relating to the removal of Cxbladder test from the coverage of Medicare contractor, Novitas.Pacific Edge's shares were up 7% in New Zealand and  10% in Australia.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PEB.AU","XAO.AU","XKO.AU","XJO.AU","BK7067"],"gpt_icon":0},{"id":"2505651657","title":"New Zealand Shares Flat, Asian Shares Mixed Amid Tariff Fears; Inflation Steady in Q4 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2505651657","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505651657?lang=en_us&edition=fundamental","pubTime":"2025-01-22 12:40","pubTimestamp":1737520801,"startTime":"0","endTime":"0","summary":"New Zealand shares were subdued on Wednesday while Asian shares were mixed as US President Donald Trump's initial policy agenda continued to unfold.The S&P/NZX 50 Index was little changed at 13,037.14","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CNU.AU","BK7067","PEB.AU","NZ20C.NZ","T10G.NZ","NZ50G.NZ","BK7015"],"gpt_icon":0},{"id":"2505084733","title":"Australian Shares to Open Higher Amid Wall Street Gains; Woodside 2024 Production at Top End of Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2505084733","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505084733?lang=en_us&edition=fundamental","pubTime":"2025-01-22 06:44","pubTimestamp":1737499444,"startTime":"0","endTime":"0","summary":"Australian shares are poised to open higher, tracking gains from Wall Street following US President Donald Trump's first day in office.In macroeconomic news, the Westpac Leading Index is slated for re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","BK7067","WDS.AU","XKO.AU","XJO.AU","BK7142","PEB.AU"],"gpt_icon":0},{"id":"2505478035","title":"Pacific Edge's Laboratory Throughput Up 0.7% in Fiscal Q3; US Injunction Mulled in Wake of Novitas Decision","url":"https://stock-news.laohu8.com/highlight/detail?id=2505478035","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505478035?lang=en_us&edition=fundamental","pubTime":"2025-01-22 05:48","pubTimestamp":1737496102,"startTime":"0","endTime":"0","summary":"Pacific Edge  reported total laboratory throughput of 7,092 tests for the fiscal third quarter ended December 2024, a 0.7% rise from the prior three-month period, according to a Wednesday filing with the Australian and New Zealand bourses.Its sales force efficiency metric was flat at 379 tests per sales of a full-time employee. Tests per unique US ordering clinician was up 9.1% to 7.The cancer diagnostics company plans to seek a preliminary injunction in the US relating to the removal of its flagship Cxbladder test from the coverage of Medicare contractor, Novitas.Pacific Edge said this move is \"on the basis of the irreparable harm\" that Novitas' decision would cause its business if efforts to negotiate a withdrawal or revision fail, per the filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","PEB.AU"],"gpt_icon":0},{"id":"2503416233","title":"New Zealand Shares Fall as Upbeat US Jobs Report Weighs on Rate Cut Bets; Pacific Edge Crashes 55% on Medicare Decision","url":"https://stock-news.laohu8.com/highlight/detail?id=2503416233","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503416233?lang=en_us&edition=fundamental","pubTime":"2025-01-13 12:38","pubTimestamp":1736743114,"startTime":"0","endTime":"0","summary":"Kiwi shares fell Monday along with Asian equities as the US' better-than-expected jobs report dampened hopes for rate cuts.The S&P/NZX 50 Index fell 0.5%, or 68.65 points, to close at 12,827.33.Asian ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["T10G.NZ","NZ20C.NZ","NZ50G.NZ","PEB.AU","BK7067"],"gpt_icon":0},{"id":"2503187314","title":"Pacific Edge Plunges to All-Time Low as Confirms US Medicare Exclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=2503187314","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503187314?lang=en_us&edition=fundamental","pubTime":"2025-01-13 09:50","pubTimestamp":1736733043,"startTime":"0","endTime":"0","summary":"Pacific Edge's  Australian and New Zealand shares tumbled to all-time lows after the company received confirmation that its flagship Cxbladder test would no longer be covered by a US Medicare contractor.In a Monday filing with the Australian and New Zealand bourses, the cancer diagnostics company called the decision \"flawed\" and said that Novitas \"continues to misunderstand the current standard of care in evaluating hematuria patients.\"Novitas is the Medicare administrative contractor with jurisdiction for Pacific Edge's US laboratory.The company said work is underway to cut its expense base until it regains reliable Medicare coverage and that it is \"well placed\" to fund the re-coverage process.If not challenged, the finalized decision would become effective 45 days from the date of publishing, which means reimbursement of Pacific Edge's Cxbladder tests would end on Feb. 23.Pacific Edge's shares plunged 54% in Australia and by 55% in New Zealand in recent Monday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","BK7067","XKO.AU","XAO.AU","PEB.AU"],"gpt_icon":0},{"id":"2503927523","title":"ASX Market Open: Sharp Oz downturn after Wall Street bucks on ‘surprising’ jobs data | Jan 13, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503927523","media":"The Market Herald","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503927523?lang=en_us&edition=fundamental","pubTime":"2025-01-13 05:39","pubTimestamp":1736717940,"startTime":"0","endTime":"0","summary":"The Australian market is about to be barraged with a very harsh slide on Wall Street from Friday, where surprising jobs data and falling unemployment figures jolted the January rally into a deep red decline across all sectors.The S&P 500 lost 1.54% last Friday, while the Dow Jones trimmed 1.6%; the U.S. indices are now only up around 0.8% since Donald Trump’s election victory.The ASX 200 futures are now tipping a 71-point drop for the local bourse, to be down around 0.86% at open; a decline compounded by the fact the Aussie dollar is taking a beating.Back home, Star Entertainment Group’s  slow-motion blow-up seems to be stretching into this week with the gov’t warning it won’t help things. The Star collapsing would be the first Oz casino crash since late 1998.The takeover saga around Insignia  rolls on too – while the Brookfield approach reported last week likely never happened, it looks like Bain Capital will now match leading sutor CC Capital’s $2.9 billion bid today.That’s Market Op","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-open-sharp-oz-downturn-after-wall-street-bucks-on-surprising-jobs-data-jan-13-2025-2025-01-13/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7062","BK7504","SGR.AU","VUL.AU","IFL.AU","BK7095","PEB.AU","BK7067","BK7078"],"gpt_icon":0},{"id":"2502303076","title":"Pacific Edge Requests Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2502303076","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502303076?lang=en_us&edition=fundamental","pubTime":"2025-01-10 07:24","pubTimestamp":1736465057,"startTime":"0","endTime":"0","summary":"Pacific Edge  requested that its securities be placed in trading halt ahead of the market open on Friday until an announcement is made about the implications of a draft Local Coverage Determination  by Novitas, according to a same-day filing with the Australian bourse.The LCD concerns Medicare's reimbursement of the company's Cxbladder bladder cancer detection test, the filing said.The trading halt will remain in place until the start of trading on the Australian Securities Exchange and the New Zealand Stock Exchange on Jan. 13, per the filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","BK7067","PEB.AU","XKO.AU","XJO.AU","LCD.AU"],"gpt_icon":0},{"id":"2492846525","title":"3 Promising Penny Stocks With Market Caps Of US$50M","url":"https://stock-news.laohu8.com/highlight/detail?id=2492846525","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492846525?lang=en_us&edition=fundamental","pubTime":"2024-12-20 13:06","pubTimestamp":1734671216,"startTime":"0","endTime":"0","summary":"As global markets navigate a landscape of mixed economic signals, including rate cuts by the ECB and SNB and expectations for a Fed rate cut, investors are keenly observing how these shifts might impact different sectors. Despite the underperformance of smaller-cap stocks compared to their larger counterparts, penny stocks continue to draw interest due to their unique potential. While the term \"penny stocks\" may seem outdated, these smaller or newer companies can still offer significant opportunities when backed by strong financials. In this article, we explore three penny stocks that stand out for their balance sheet strength and growth potential.Overview: Pacific Edge Limited is a cancer diagnostics company that focuses on researching, developing, and commercializing diagnostic and prognostic tools for early cancer detection and management in New Zealand, the United States, and internationally, with a market cap of NZ$95.81 million.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/iEsa6cyhMcKmkldWAL3Urg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f4bf946057709b1ca750da142978bde5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/iEsa6cyhMcKmkldWAL3Urg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f4bf946057709b1ca750da142978bde5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-promising-penny-stocks-market-050656323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LBL.AU","BK7067","EVO.AU","BK7132","PEB.AU","BK7088"],"gpt_icon":0},{"id":"2481535450","title":"Pebblebrook Extends $787 Million in Debt Maturities, Including Term Loan, Credit Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2481535450","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481535450?lang=en_us&edition=fundamental","pubTime":"2024-11-05 00:28","pubTimestamp":1730737692,"startTime":"0","endTime":"0","summary":"Pebblebrook Hotel Trust  said Monday it has extended $787 million in debt maturities, including $185.2 million of its $200 million 2025 term loan to 2029.The company also extended $602 million of its $650 million senior unsecured revolving credit facility to 2029.The credit facility has two six-month extension options and is undrawn and fully available, Pebblebrook said.Pricing on the term loan and credit facility remains unchanged, the company said.Shares of Pebblebrook were 2.9% higher in recent trading.Price: 12.20, Change: +0.35, Percent Change: +2.95","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4218","BK7067","BK4181","PEB.AU","PEB"],"gpt_icon":0},{"id":"2479155887","title":"Here's Why We're Watching Pacific Edge's (NZSE:PEB) Cash Burn Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2479155887","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479155887?lang=en_us&edition=fundamental","pubTime":"2024-10-31 09:28","pubTimestamp":1730338117,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly.Given this risk, we thought we'd take a look at whether Pacific Edge  shareholders should be worried about its cash burn. In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. Let's start with an examination of the business' cash, relative to its cash burn.On this analysis of Pacific Edge's cash burn, we think its revenue growth was reassuring,","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-were-watching-pacific-012837356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["PEB","BK7067","BK4181","PEB.AU","BK4218"],"gpt_icon":0},{"id":"2474665012","title":"New Zealand Shares Rally on Central Bank's Supersized Rate Cut","url":"https://stock-news.laohu8.com/highlight/detail?id=2474665012","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474665012?lang=en_us&edition=fundamental","pubTime":"2024-10-09 12:44","pubTimestamp":1728449070,"startTime":"0","endTime":"0","summary":"New Zealand shares climbed on Wednesday after the central bank slashed its key rate by half a percentage point in a move widely expected by economists.The S&P/NZX 50 Index gained 1.8%, or 220.1 points, to close at 12,776.13. The rally followed the Reserve Bank of New Zealand's decision to cut the official cash rate by 50 basis points to 4.75%.In announcing its decision, the central bank said annual consumer price inflation is now converging on the 2% midpoint of its 1% to 3% target. The Monetary Policy Committee also said the move is needed \"to achieve and maintain low and stable inflation, while seeking to avoid unnecessary instability in output, employment, interest rates, and the exchange rate.\"In corporate news, Pacific Edge's  shares fell more than 3% at market close after the cancer diagnostics company reported that tests processed at its laboratories in the three months to September were 2% lower than the prior quarter at 7,045.Cooks Coffee  reported group sales of NZ$33.8 milli","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NZ20C.NZ","BK7067","NZ50G.NZ","PEB.AU","T10G.NZ"],"gpt_icon":0},{"id":"2474287218","title":"Pacific Edge Tests Processed in Fiscal Q2 Fall 2%; Shares Down 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474287218","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474287218?lang=en_us&edition=fundamental","pubTime":"2024-10-09 06:29","pubTimestamp":1728426553,"startTime":"0","endTime":"0","summary":"Cancer diagnostics company Pacific Edge  said tests processed at its laboratories in the three months to the end of September were 2% lower than the prior quarter at 7,045, according to a Wednesday filing with the Australian and New Zealand bourses.Asia Pacific volumes rose 6.2% to 1,363 tests from 1,283 in fiscal Q1, reflecting increased volumes in New Zealand and small growth from Australia and Asian distributors, the filing stated.Group test volumes for the half year fell 22% to 14,233 from 18,240 in the first half of fiscal 2024, according to the filing.Pacific Edge shares fell past 4% in recent Wednesday trade in New Zealand.Price : $0.16, Change: $-0.0070, Percent Change: -4.32%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4125","T10G.NZ","BK7067","AUD","XKO.AU","XAO.AU","XJO.AU","NZ50G.NZ","PEB.AU","NZ20C.NZ"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PEB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PEB.AU\",market:\"AU\",,,undefined,":[]}}